Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help
doctors plan better treatment for patients receiving isotretinoin.
PURPOSE: This clinical trial is studying the side effects and best dose of isotretinoin in
treating young patients with high-risk neuroblastoma.